Citigroup
ZLAB icon

Citigroup’s Zai Lab ZLAB Stock Holding History

Citigroup’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-24,800
Closed -$825K – 5746
2023
Q1 		$825K Buy
+24,800
New +$952K ﹤0.01% 2707

Other funds holding ZLAB

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup's ZLAB Position: Q2 2026 in Review

Citigroup increased its Zai Lab (ZLAB) stake by 31,263% in Q2 2026, buying an estimated $5.92M and bringing the position to 300,775 shares worth $5.71M. The position accounts for ﹤0.01% of the portfolio, ranked #2034.

Citigroup first reported a position in ZLAB in Q3 2018 and has held it in 31 quarters since. The position peaked at $17M in Q1 2023. 92 funds tracked by Wall St. Rank hold ZLAB as of Q2 2026.

  • Citigroup held 300,775 shares of Zai Lab worth $5.71M as of Q2 2026.
  • Citigroup bought 299,816 Zai Lab shares in Q2 2026, an estimated $5.92M.
  • Zai Lab made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #2034 holding.
  • Citigroup first reported a position in Zai Lab in Q3 2018 and has held it in 31 quarters since.
  • Citigroup's Zai Lab position peaked at $17M in Q1 2023.
  • 92 funds tracked by Wall St. Rank held Zai Lab as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.